Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 261: Transforming Lives with Advanced BioMaterials with Dr. Juliana Blum of BioAesthetics
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 259: The Patient Voice in Clinical Trials with Tom Croce of Jazz Pharmaceuticals
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 257: Biogen’s $2B Investment in North Carolina’s RTP with Nicole Murphy
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 247: Reimagining Cell Therapy for Solid Tumors with Ming-Wei Chen and Fangheng Zhou of RephImmune
Executive Actions Impact Federally Funded Research: What Institutions Should Do Now – Diagnosing Health Care Video Podcast
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 215: Bioactives for Human Health with Jan-Willem van Klinken of Brightseed
False Claims Act Insights - Eureka! Government Investigators Seek Out Research Misconduct
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 194: Workforce Development for the Life Sciences Industry with David Stefanich of Rymedi
Episode 185: America’s Bioeconomy with Sarah Glaven, White House Research Biologist
Wiley's 10 Key Trade Developments: The CHIPS Act and Inflation Reduction Act (IRA)
Episode 183: Site Development for Life Sciences Companies with Adam Bruns of Site Selection Magazine
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 181: South Carolina’s Life Sciences Economy with Ashely Teasdel, Deputy Secretary of SC Department of Commerce
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 180: SCBIO and the Life Sciences Industry in South Carolina with James Chappell, SCBIO CEO
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 179: Obesity Effects on the Workforce & Economy with Tim Dall, Healthcare Economist
Stoel Rives | Deeply Rooted Podcast S3E3: AgTech Innovation and Robotics with Burro CEO Charlie Andersen
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 171: Laura Gunter, President of the NC Life Sciences Organization
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 169: Shirley Paddock, Senior VP of Clinical Development, Syneos Health
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 166 — Christine Vannais, COO of Fujifilm Diosynth Biotechnologies
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 165: Doug Edgeton, President and CEO of the North Carolina Biotechnology Center
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 163: David Ellison, Chief Data Scientist for Lenovo’s Infrastructure Solutions Group
While the tech industry prepares for an Executive Order (EO) seeking to limit state regulation of AI, President Trump instead issued an EO titled “Launching the Genesis Mission” on November 24, 2025. The Genesis Mission (the...more
As kids woke to naughty elves on their shelves on 1 December, ministers also provided UK-based pharmaceutical companies a shot-in-the-arm behind door #1 of their advent calendars. The UK government announced on Monday, 1...more
T-21 Days Until the Expiration of the ACA eAPTCs: On Thursday, the Senate is expected to vote on a proposal from Democrats that would extend the expiring Affordable Care Act enhanced premium tax credits (eAPTCs) for three...more
The unveiling of this year’s Autumn Budget followed an unprecedented level of speculation on the potential “smorgasboard” of tax raising measures to be introduced by Chancellor Rachel Reeves to rebalance the UK’s fiscal gaps...more
This week I had the pleasure of speaking with Dr. Adelina Voutchkova, Director of Sustainable Development at the American Chemical Society (ACS), and my colleague Dr. Richard Engler, B&C’s Director of Chemistry, to discuss...more
Recorded live at the NCLifeSci 2025 Annual Meeting, hosts Heather Matthews and Lauren DeMoss chat with Dr. Juliana Blum, CEO of BioAesthetics, a biomaterials company pioneering next-generation acellular grafts for tissue...more
AI speeds discovery, but unclear patent rights for AI-designed drugs threaten exclusivity, returns, and drug-development economics....more
The White House recently issued an executive order launching the “Genesis Mission,” a US Department of Energy–led national initiative designed to accelerate scientific discovery using advanced artificial intelligence. The...more
Securing a grant from the Israel Innovation Authority (IIA) is a major vote of confidence and a critical financial boost for any R&D company. However, the funding comes with a complex set of legal, regulatory, and financial...more
Acquisitions are part of deal acceleration in Artificial Intelligence, Digital Clinical Research, and Observability Technologies. Marvell Technology, Thermo Fisher Scientific, and Palo Alto Networks have each announced...more
This article is the second installment in our three-part series, Artificial Intelligence as Intellectual Property or “AI as IP™”, which explores how artificial intelligence assets should be treated as a form of intellectual...more
In complex commercial agreements, parties are often required to use a specified level of “effort” when performing their obligations. But what distinguishes “best efforts,” “commercially reasonable efforts” or “good faith...more
While larger companies typically dominate patent filings, if you’re a small or mid-size business, understanding how these giants use patents can offer valuable insights for shaping your own Intellectual Property (IP)...more
On December 1, 2025, the Department of Energy (DOE) publicly announced its decision to allocate up to $134 million in new funding to enhance domestic supply chains for rare earth elements (REEs). REEs are 17 elements...more
President Trump’s Executive Order 14363, titled “Launching the Genesis Mission," outlines a potentially transformative national effort to turbocharge artificial intelligence growth to win the technological “cold war” over AI...more
Being a research integrity officer (RIO) is a challenging and high-stress, high-stakes job, working to prevent misconduct and investigating allegations of fabrication, falsification and plagiarism....more
In the current interconnected health research ecosystem, comprehensive and secure access to health data is key to accelerate drug discovery and improve patient outcomes. ...more
The US Patent and Trademark Office recently issued revised guidance clarifying that only natural persons may be named as inventors on patent applications involving AI-assisted inventions. The guidance rescinds earlier...more
On November 25, 2025, the National Security Commission on Emerging Biotechnology (NSCEB) announced the publication of a discussion paper entitled “The Future of Science: A Playbook for Accelerating American Innovation.”...more
The animal health industry is rapidly evolving through innovation, investment, and changes in consumer behavior. From biotechnology to online distribution, experts say the sector reflects both scientific progress and the...more
As part of the AI Action Plan, President Trump issued an executive order for the establishment of the Genesis Mission, an integrated artificial intelligence platform for Federal scientific datasets. Background Information...more
Introduction - For founders and early employees of pharmaceutical startups, few assets are as critical—or as vulnerable—as your intellectual property (IP). Securing and defending your innovations is not only central to...more
On Thanksgiving Eve, November 26, 2025, the White House Office of Science and Technology Policy (OSTP) requested input from interested parties on federal policy updates “that aim to accelerate the American scientific...more
Introduction - Far too often, startup founders treat intellectual property (IP)—especially patents—like an item on a to-do list. “We’ll file once the science is ready,” they say. But here’s the reality: IP isn’t just a box...more
France will introduce in 2026 a “fast-track” pathway aimed at accelerating the authorisation of certain mono-national clinical trials. Reserved in particular for early-phase studies, serious diseases without available...more